Healthcare providers may be misapplying opioid guidelines, CDC says

Healthcare providers may be misapplying opioid guidelines, CDC says

Publication date: May 15, 2019

In 2016, the Centers for Disease Control and Prevention (CDC) released guidelines for medical professionals to follow in an effort to reduce the number of opioid prescriptions; however, the agency is now saying that many doctors may be misapplying these guidelines, to the detriment of patients.

Though not applicable to cancer patients or those in end-of-life or palliative care, the guidelines are broken down into three categories: -The intent of the CDC guidelines was to individualize treatment, but the overly restrictive prescribing policies created by legislatures and payers have led to unintended harm for some patients,” Dr. Kroenke said.

Despite being designed to help prevent overdoses, Dr. Kroenke discovered that many physicians have become too restrictive in their opioid prescriptions and too rigid in following the guidelines, even when the drugs can be helpful to patients.

Dr. Kroenke and his fellow American Academy of Pain Medicine Foundation panelists agree with the basis of the CDC’s guidelines, but they want policymakers to ensure all patients are given the care that is most beneficial to their individual needs going forward.

Concepts Keywords
ASA Heroin
CDC Drug overdose
Chronic Pain Pain management
Healthcare Healthcare providers
Opioid Pain
Opioids Chronic pain benefit
Pain Pain management
Pain Management Surgery
Palliative Care Opioids
Stigma Psychoactive drugs
Survey RTT
Morphine
Medical emergencies
Euphoriants

Semantics

Type Source Name
gene UNIPROT ARSA
drug DRUGBANK Acetylsalicylic acid
gene UNIPROT SMIM10L2A
gene UNIPROT SMIM10L2B
disease DOID cancer
disease MESH cancer
gene UNIPROT BEST1
disease MESH chronic pain
disease MESH suffering

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *